Stockreport

Longeveron Announces Closing of $5.2 Million Public Offering [Yahoo! Finance]

Longeveron Inc. - Class A Common stock  (LGVN) 
PDF developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (HLHS), Alzheimer's disease and Aging-rel [Read more]